Comparison of magnetic resonance-guided high-intensity focused ultrasound with uterine artery embolization for the treatment of uterine myoma: A systematic literature review and meta-analysis

This study aimed to compare the outcomes of magnetic resonance-guided (MR-g) high-intensity focused ultrasound (HIFU) with uterine artery embolization (UAE) for the treatment of uterine myoma. A systematic literature review and meta-analysis was conducted using database searches of Medline, Cochrane...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Taiwanese journal of obstetrics & gynecology Ročník 59; číslo 5; s. 691 - 697
Hlavní autori: Jeng, Cherng-Jye, Long, Cheng-Yu, Chuang, Linus T.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: China (Republic : 1949- ) Elsevier B.V 01.09.2020
Elsevier
Predmet:
Ablation
Fibroid
High-intensity focused ultrasound
Internal Medicine
Obstetrics and Gynecology
Quality of life
Uterine myoma
Uterine myoma
Fibroid
Ablation
High-intensity focused ultrasound
Quality of life
ISSN:1028-4559, 1875-6263, 1875-6263
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:This study aimed to compare the outcomes of magnetic resonance-guided (MR-g) high-intensity focused ultrasound (HIFU) with uterine artery embolization (UAE) for the treatment of uterine myoma. A systematic literature review and meta-analysis was conducted using database searches of Medline, Cochrane, EMBASE, and Google Scholar. Articles were searched through March 25, 2020. Outcomes of interest were Symptom Severity Score (SSS), Health-related Quality of Life (HRQoL), re-intervention rate, and rate of adverse reactions in patients with uterine myoma. Four studies were included with a total of 207 patients with uterine myomas who received MR-g HIFU and 201 who received UAE. UAE was associated with a greater reduction in SSS, improved HRQoL, and a significantly lower re-intervention rate compared with MR-g HIFU in 3 of 4 included studies. No significant differences were found in the incidence and severity of adverse events between treatment arms in one study, but differences were observed in the percentage of adverse reactions in another. Published evidence suggests that the efficacy of MR-g HIFU may not be superior to that of UAE in the treatment of uterine myoma.
Bibliografia:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:1028-4559
1875-6263
1875-6263
DOI:10.1016/j.tjog.2020.07.012